Vasculitides of the gastrointestinal tract. Semin Diag Pathol
Department of Pathology, Toronto General Hospital/University Health Network, Toronto, ON, Canada. Seminars in Diagnostic Pathology
(Impact Factor: 2.56).
05/2009; 26(2):77-88. DOI: 10.1053/j.semdp.2009.06.001
Systemic vasculitis is often not considered as a possible diagnosis by clinicians because of its low prevalence compared with other more common diseases. Vasculitis can affect any end organ, and it is therefore often missed early on in disease progression. Gastrointestinal (GI) manifestations of vasculitis are considered rare and the presentation is often nonspecific. However, if there is significant involvement of the major vessels of the gastrointestinal system, life-threatening sequelae, including perforation and bowel ischemia, may occur. This makes early and immediate management crucial to improve long-term morbidity and mortality. Diagnosis of various GI vasculitides often relies on correlation of clinical manifestations with pathology and additional investigations. This paper reviews the various vasculitides that affect the GI tract, including systemic lupus erythematosus, mixed connective tissue disease, Henoch Schönlein purpura, polyarteritis nodosa, Churg-Strauss syndrome, Wegener's granulomatosis, microscopic polyangiitis, enterocolic lymphocytic phlebitis, and Behcet's disease. Segmental arterial mediolysis, mistakenly believed to be a vasculitis, is also discussed.
Available from: Awad Ali Mohamed Ahmed Alawad
- "Prognosis of untreated patients has been improved by use of steroids with 48% survival at 5 years. The combination of cyclophosphamide with prednisolone results in 96% remission (Ahn et al., 2009). "
[Show abstract] [Hide abstract]
ABSTRACT: Polyarteritis nodosa is a form of vasculitis that affects several organs. Gastrointestinal involvement is
frequent, but cases in which the gastrointestinal tract is the only site of disease are rare. In this paper,
we report a case of a 40 -year- old patient with polyarteritis nodosa restricted to small part of the small
intestine, which underwent resection and anastomosis. Laparotomy was performed despite normal
radiological findings. He underwent resection of the infracted segment. Histopathological examination
confirmed the diagnosis. Thus, a pathological diagnosis of ischaemic infarction due to polyarteritis
Nodosa (PAN) was made. The patient had no other signs of chronic vasculitis and for this reason
surgical treatment resolved the clinical symptoms.
[Show abstract] [Hide abstract]
ABSTRACT: Primary systemic vasculitides are rare and primarily classified according to the size of the vessels predominantly affected. Secondary vasculitides can be caused by infection or drug or develop as a complication of cancer or other systemic disease like rheumatoid arthritis. Gastrointestinal manifestations occur at variable frequencies in vasculitis patients and may reveal the disease (15% of the patients). Abdominal pain, nausea, vomiting, and diarrheas are common, but non specific, manifestations. Mucosal inflammation, purpuric infiltrate or necrosis and ulceration (possibly with a granulomatous appearance) can also be observed. Gastrointestinal ischemia, bowel infarction, intestinal perforation, especially of the small bowel, pancreatitis, and gastrointestinal bleeding are more severe manifestations. Prompt and combined medical and, when necessary, surgical management is mandatory. Ten-year survival rate of patients with primary systemic necrotizing vasculitides is now about 80% in the absence of severe visceral involvement or in case of only minor gastrointestinal manifestations. Conversely, at 5 years, survival rate is only 56% for patients with severe and surgical gastrointestinal manifestations.
Available from: Gary Wild
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.